Antares Pharma, Inc. (ATRS)

[H2R]

I like SoS too :)

The one thing I'm wondering about is 'the other' generic Epipen, Symjempi from Adamis Pharmaceutical, which should hit the market "soon" (?) via their partner Sandoz (a US branch? of Novartis), hence a potential competitor on that front. I have some shares of ADMP just in case. I think between the two of them, they will dominate the Epipen market.

Anyways, for now, it's ATRS.

Best of luck with your investments!